Equities analysts expect that McKesson Co. (NYSE:MCK) will report $52.00 billion in sales for the current quarter, Zacks reports. Six analysts have provided estimates for McKesson’s earnings, with estimates ranging from $51.51 billion to $52.58 billion. McKesson reported sales of $50.13 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 3.7%. The firm is expected to report its next quarterly earnings results before the market opens on Thursday, February 1st.

On average, analysts expect that McKesson will report full year sales of $52.00 billion for the current year, with estimates ranging from $204.58 billion to $206.37 billion. For the next fiscal year, analysts expect that the company will post sales of $209.59 billion per share, with estimates ranging from $203.19 billion to $214.45 billion. Zacks’ sales averages are a mean average based on a survey of research firms that cover McKesson.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Thursday, October 26th. The company reported $3.28 earnings per share for the quarter, topping analysts’ consensus estimates of $2.78 by $0.50. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.69 billion. McKesson had a net margin of 2.24% and a return on equity of 24.87%. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm posted $2.94 earnings per share.

A number of equities analysts have recently weighed in on the stock. Royal Bank of Canada assumed coverage on shares of McKesson in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $168.00 price target on the stock. Evercore ISI assumed coverage on shares of McKesson in a research report on Thursday, January 4th. They set an “outperform” rating and a $179.00 price target on the stock. Jefferies Group set a $165.00 price target on shares of McKesson and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Cowen raised shares of McKesson from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $176.00 to $189.00 in a research report on Tuesday, October 10th. Finally, ValuEngine cut shares of McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Two analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $174.64.

In related news, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.20% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of MCK. IHT Wealth Management LLC lifted its position in McKesson by 64.2% during the 2nd quarter. IHT Wealth Management LLC now owns 486 shares of the company’s stock worth $1,027,000 after buying an additional 190 shares in the last quarter. Captrust Financial Advisors bought a new stake in McKesson during the 2nd quarter worth about $107,000. Harvest Fund Management Co. Ltd bought a new stake in McKesson during the 2nd quarter worth about $125,000. WFG Advisors LP lifted its position in McKesson by 5.0% during the 2nd quarter. WFG Advisors LP now owns 859 shares of the company’s stock worth $141,000 after buying an additional 41 shares in the last quarter. Finally, CWH Capital Management Inc. bought a new stake in McKesson during the 2nd quarter worth about $165,000. 87.88% of the stock is currently owned by institutional investors and hedge funds.

McKesson (NYSE:MCK) opened at $166.25 on Monday. The firm has a market cap of $34,658.97, a price-to-earnings ratio of 7.88, a PEG ratio of 1.70 and a beta of 1.23. McKesson has a 52-week low of $133.82 and a 52-week high of $169.29. The company has a current ratio of 1.05, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Investors of record on Friday, December 1st were given a $0.34 dividend. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $1.36 annualized dividend and a yield of 0.82%. McKesson’s dividend payout ratio is currently 6.45%.

TRADEMARK VIOLATION WARNING: “$52.00 Billion in Sales Expected for McKesson Co. (MCK) This Quarter” was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/15/52-00-billion-in-sales-expected-for-mckesson-co-mck-this-quarter.html.

About McKesson

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Get a free copy of the Zacks research report on McKesson (MCK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.